• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.铜绿假单胞菌呼吸道分离株弹性蛋白酶活性与 ICU 死亡率的关系。
Chest. 2021 Nov;160(5):1624-1633. doi: 10.1016/j.chest.2021.04.015. Epub 2021 Apr 17.
2
Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pneumonia in Critically Ill Patients: An Exploratory Study.外切酶 Y 导致危重症肺炎患者发生靶器官功能障碍:一项探索性研究。
Toxins (Basel). 2020 Jun 4;12(6):369. doi: 10.3390/toxins12060369.
3
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.重症监护病房铜绿假单胞菌肺炎患者的临床转归。
Intensive Care Med. 2013 Apr;39(4):682-92. doi: 10.1007/s00134-013-2828-9. Epub 2013 Feb 1.
4
Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis.血小板反应蛋白-1 通过限制细胞外基质的蛋白水解来防止病原体引起的肺损伤。
JCI Insight. 2018 Feb 8;3(3). doi: 10.1172/jci.insight.96914.
5
Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia.影响菌血症性肺炎患者预后的铜绿假单胞菌的临床和细菌特征。
Int J Antimicrob Agents. 2021 Dec;58(6):106450. doi: 10.1016/j.ijantimicag.2021.106450. Epub 2021 Oct 10.
6
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.铜绿假单胞菌肺炎中三种主要毒力因子的相对贡献。
Crit Care Med. 2011 Sep;39(9):2113-20. doi: 10.1097/CCM.0b013e31821e899f.
7
Analysis of quorum sensing-dependent virulence factor production and its relationship with antimicrobial susceptibility in Pseudomonas aeruginosa respiratory isolates.分析铜绿假单胞菌呼吸道分离株中群体感应依赖性毒力因子的产生及其与抗菌药物敏感性的关系。
Clin Microbiol Infect. 2010 Dec;16(12):1770-5. doi: 10.1111/j.1469-0691.2010.03177.x.
8
Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.抗生素使用时长对铜绿假单胞菌呼吸机相关性肺炎患者临床事件的影响:一项随机对照研究的研究方案
Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3.
9
Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.黄连素与阿奇霉素对从囊性肺纤维化患者分离出的铜绿假单胞菌的体外和体内协同活性
Cell Physiol Biochem. 2017;42(4):1657-1669. doi: 10.1159/000479411. Epub 2017 Jul 24.
10
Heterogeneous production of proteases from Brazilian clinical isolates of Pseudomonas aeruginosa.巴西铜绿假单胞菌临床分离株蛋白酶的异质性产生
Enferm Infecc Microbiol Clin. 2017 Dec;35(10):630-637. doi: 10.1016/j.eimc.2016.06.015.

引用本文的文献

1
Risk factors for multidrug resistant and carbapenem resistant Pseudomonas aeruginosa bloodstream infections among inpatients in Central and East China.中国中部和东部地区住院患者中多重耐药和碳青霉烯耐药铜绿假单胞菌血流感染的危险因素
Sci Rep. 2025 Jul 1;15(1):20719. doi: 10.1038/s41598-025-07820-x.
2
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection.基因组毒力标志物与铜绿假单胞菌血流感染患者的严重预后相关。
Commun Med (Lond). 2024 Dec 11;4(1):264. doi: 10.1038/s43856-024-00696-4.
3
Evolutionary loss of an antibiotic efflux pump increases quorum sensing mediated virulence .抗生素外排泵的进化性缺失增强了群体感应介导的毒力。
Res Sq. 2024 Nov 12:rs.3.rs-5391023. doi: 10.21203/rs.3.rs-5391023/v1.
4
Effect of cell-free culture on bacterial pathogens isolated from cystic fibrosis patients: and studies.无细胞培养对从囊性纤维化患者中分离出的细菌病原体的影响:及研究。
Front Microbiol. 2024 Sep 16;15:1440090. doi: 10.3389/fmicb.2024.1440090. eCollection 2024.
5
In Vivo Evolution of a Klebsiella pneumoniae Capsule Defect With wcaJ Mutation Promotes Complement-Mediated Opsonophagocytosis During Recurrent Infection.在复发性感染过程中,携带 wcaJ 突变的肺炎克雷伯菌荚膜缺陷的体内进化促进补体介导的调理吞噬作用。
J Infect Dis. 2024 Jul 25;230(1):209-220. doi: 10.1093/infdis/jiae003.
6
Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University.耶鲁大学针对铜绿假单胞菌的噬菌体紧急治疗的优化准备方案。
Sci Rep. 2024 Feb 1;14(1):2657. doi: 10.1038/s41598-024-52192-3.
7
Quercetin: a promising virulence inhibitor of Pseudomonas aeruginosa LasB in vitro.槲皮素:体外抑制铜绿假单胞菌 LasB 毒力的一种有前景的抑制剂。
Appl Microbiol Biotechnol. 2024 Dec;108(1):57. doi: 10.1007/s00253-023-12890-w. Epub 2024 Jan 5.
8
Inhibitors of the Elastase LasB for the Treatment of Lung Infections.用于治疗肺部感染的弹性蛋白酶LasB抑制剂。
ACS Cent Sci. 2023 Oct 27;9(12):2205-2215. doi: 10.1021/acscentsci.3c01102. eCollection 2023 Dec 27.
9
Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.铜绿假单胞菌 LasB 弹性蛋白酶表达水平升高与囊性纤维化患者早期感染有关。
Sci Rep. 2023 Aug 30;13(1):14208. doi: 10.1038/s41598-023-41333-9.
10
An integrated multi-omics analysis of identifies distinct molecular characteristics in pulmonary infections of Pseudomonas aeruginosa.一项综合的多组学分析确定了铜绿假单胞菌肺部感染的不同分子特征。
PLoS Pathog. 2023 Aug 29;19(8):e1011570. doi: 10.1371/journal.ppat.1011570. eCollection 2023 Aug.

本文引用的文献

1
Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury.血小板抑制凋亡的肺上皮细胞死亡,并保护小鼠免受感染引起的肺损伤。
Blood Adv. 2019 Feb 12;3(3):432-445. doi: 10.1182/bloodadvances.2018026286.
2
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study.铜绿假单胞菌在慢性阻塞性肺疾病频繁住院加重患者中的作用:一项前瞻性多中心研究。
Respiration. 2018;96(5):417-424. doi: 10.1159/000490190. Epub 2018 Jul 24.
3
Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis.血小板反应蛋白-1 通过限制细胞外基质的蛋白水解来防止病原体引起的肺损伤。
JCI Insight. 2018 Feb 8;3(3). doi: 10.1172/jci.insight.96914.
4
Virulence adaptations of isolated from patients with non-cystic fibrosis bronchiectasis.从非囊性纤维化支气管扩张症患者中分离出的毒力适应性
Microbiology (Reading). 2016 Dec;162(12):2126-2135. doi: 10.1099/mic.0.000393.
5
Cystic fibrosis-adapted quorum sensing mutants cause hyperinflammatory responses.囊性纤维化适应性群体感应突变体引发过度炎症反应。
Sci Adv. 2015 Jul;1(6). doi: 10.1126/sciadv.1500199. Epub 2015 Jul 31.
6
The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.铜绿假单胞菌导致急性肺损伤的分子机制:从细菌发病机制到宿主反应。
J Intensive Care. 2014 Feb 18;2(1):10. doi: 10.1186/2052-0492-2-10. eCollection 2014.
7
Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.铜绿假单胞菌在囊性纤维化患者体内的趋同进化和适应。
Nat Genet. 2015 Jan;47(1):57-64. doi: 10.1038/ng.3148. Epub 2014 Nov 17.
8
Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.医院获得性耐药和多重耐药铜绿假单胞菌感染的临床和经济后果:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2014 Oct 20;3(1):32. doi: 10.1186/2047-2994-3-32. eCollection 2014.
9
Txc, a new type II secretion system of Pseudomonas aeruginosa strain PA7, is regulated by the TtsS/TtsR two-component system and directs specific secretion of the CbpE chitin-binding protein.铜绿假单胞菌 PA7 新型 II 型分泌系统 Txc 受 TtsS/TtsR 双组分系统调控,并指导 CbpE 几丁质结合蛋白的特异性分泌。
J Bacteriol. 2014 Jul;196(13):2376-86. doi: 10.1128/JB.01563-14. Epub 2014 Apr 18.
10
On the path to uncover the bacterial type II secretion system.在揭示细菌 II 型分泌系统的道路上。
Philos Trans R Soc Lond B Biol Sci. 2012 Apr 19;367(1592):1059-72. doi: 10.1098/rstb.2011.0204.

铜绿假单胞菌呼吸道分离株弹性蛋白酶活性与 ICU 死亡率的关系。

Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.

机构信息

Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.

出版信息

Chest. 2021 Nov;160(5):1624-1633. doi: 10.1016/j.chest.2021.04.015. Epub 2021 Apr 17.

DOI:10.1016/j.chest.2021.04.015
PMID:33878342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8628173/
Abstract

BACKGROUND

Pseudomonas aeruginosa (PA) is a common cause of respiratory infection and morbidity. Pseudomonas elastase is an important virulence factor regulated by the lasR gene. Whether PA elastase activity is associated with worse clinical outcomes in ICU patients is unknown.

RESEARCH QUESTION

Is there an association between PA elastase activity and worse host outcomes in a cohort of ICU patients?

METHODS

PA respiratory isolates from 238 unique ICU patients from two tertiary-care centers within the University of Pittsburgh Medical Center health system were prospectively collected and screened for total protease and elastase activity, biofilm production, antimicrobial resistance, and polymicrobial status. The association between pathogen characteristics and 30-day and 90-day mortality was calculated using logistic regression. For subgroup analysis, two patterns of early (≤72 h) and late sample (>72 h) collection from the index ICU admission were distinguished using a finite mixture model. Lung inflammation and injury was evaluated in a mouse model using a PA high elastase vs low elastase producer.

RESULTS

PA elastase activity was common in ICU respiratory isolates representing 75% of samples and was associated with increased 30-day mortality (adjusted OR [95% CI]: 1.39 [1.05-1.83]). Subgroup analysis demonstrated that elastase activity was a risk factor for 30- and 90-day mortality in the early sample group, whereas antimicrobial resistance was a risk factor for 90-day mortality in the late sample group. Whole genome sequencing of high and low elastase producers showed that predicted loss-of-function lasR genotypes were less common among high elastase producers. Mice infected with a high elastase producer showed increased lung bacterial burden and inflammatory profile compared with mice infected with a low elastase producer.

INTERPRETATION

Elastase activity is associated with 30-day ICU mortality. A high elastase producing clinical isolate confers increased lung tissue inflammation compared with a low elastase producer in vivo.

摘要

背景

铜绿假单胞菌(PA)是引起呼吸道感染和发病的常见原因。弹性蛋白酶是一种受 lasR 基因调控的重要毒力因子。PA 弹性酶活性是否与 ICU 患者的临床结局恶化有关尚不清楚。

研究问题

在匹兹堡大学医学中心医疗系统的两家三级保健中心的 238 名 ICU 患者队列中,PA 弹性酶活性与宿主结局恶化之间是否存在关联?

方法

前瞻性收集并筛选来自匹兹堡大学医学中心医疗系统的两家三级保健中心的 238 名 ICU 患者的 238 株 PA 呼吸道分离株,以检测总蛋白酶和弹性酶活性、生物膜形成、抗菌药物耐药性和多微生物状态。使用逻辑回归计算病原体特征与 30 天和 90 天死亡率之间的关联。对于亚组分析,使用有限混合模型区分指数 ICU 入院时早期(≤72 h)和晚期(>72 h)采集的两个样本模式。使用 PA 高弹性酶与低弹性酶产生者在小鼠模型中评估肺炎症和损伤。

结果

ICU 呼吸道分离株中常见 PA 弹性酶活性,占样本的 75%,与 30 天死亡率增加相关(调整后的比值比[95%CI]:1.39 [1.05-1.83])。亚组分析表明,弹性酶活性是早期样本组 30 天和 90 天死亡率的危险因素,而晚期样本组的抗菌药物耐药性是 90 天死亡率的危险因素。高弹性酶和低弹性酶产生者的全基因组测序显示,预测 lasR 基因缺失功能的基因型在高弹性酶产生者中较少见。与感染低弹性酶产生者的小鼠相比,感染高弹性酶产生者的小鼠肺部细菌负荷和炎症特征增加。

结论

弹性酶活性与 30 天 ICU 死亡率相关。与低弹性酶产生者相比,高弹性酶产生的临床分离株在体内引起的肺部组织炎症增加。